A detailed history of Moneco Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Moneco Advisors, LLC holds 3,977 shares of AMGN stock, worth $1.36 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,977
Previous 3,437 15.71%
Holding current value
$1.36 Million
Previous $959,000 17.0%
% of portfolio
0.1%
Previous 0.09%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

BUY
$271.18 - $309.22 $146,437 - $166,978
540 Added 15.71%
3,977 $1.12 Million
Q2 2025

Aug 13, 2025

SELL
$262.28 - $309.85 $271,984 - $321,314
-1,037 Reduced 23.18%
3,437 $959,000
Q1 2025

Aug 15, 2025

BUY
$258.59 - $327.36 $197,304 - $249,775
763 Added 22.19%
4,201 $1.31 Million
Q1 2025

May 08, 2025

BUY
$258.59 - $327.36 $197,304 - $249,775
763 Added 20.56%
4,474 $1.39 Million
Q4 2024

Aug 15, 2025

BUY
$258.78 - $328.31 $258 - $328
1 Added 0.03%
3,438 $896,000
Q4 2024

Feb 03, 2025

BUY
$258.78 - $328.31 $296,303 - $375,914
1,145 Added 44.62%
3,711 $967,000
Q2 2024

Jul 19, 2024

SELL
$262.75 - $319.31 $36,522 - $44,384
-139 Reduced 5.14%
2,566 $801,000
Q1 2024

Jul 19, 2024

BUY
$268.87 - $324.56 $161,322 - $194,736
600 Added 28.5%
2,705 $769,000
Q1 2024

Apr 25, 2024

BUY
$268.87 - $324.56 $97,868 - $118,139
364 Added 20.91%
2,105 $598,000
Q4 2023

Mar 13, 2024

SELL
$255.7 - $288.46 $55,998 - $63,172
-219 Reduced 11.17%
1,741 $501,000
Q4 2023

Feb 05, 2024

SELL
$255.7 - $288.46 $39,633 - $44,711
-155 Reduced 8.18%
1,740 $501,000
Q3 2023

Mar 13, 2024

BUY
$218.65 - $271.46 $39,138 - $48,591
179 Added 10.05%
1,960 $526,000
Q3 2023

Nov 03, 2023

BUY
$218.65 - $271.46 $39,138 - $48,591
179 Added 10.43%
1,895 $509,000
Q2 2023

Mar 13, 2024

BUY
$214.27 - $253.37 $8,785 - $10,388
41 Added 2.36%
1,781 $395,000
Q2 2023

Aug 02, 2023

SELL
$214.27 - $253.37 $27,855 - $32,938
-130 Reduced 7.04%
1,716 $380,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $228,951 - $279,052
1,014 Added 121.88%
1,846 $446,000
Q4 2022

Jan 27, 2023

BUY
$229.03 - $291.01 $190,552 - $242,120
832 New
832 $218,000
Q3 2021

Nov 03, 2021

SELL
$212.27 - $248.7 $184,250 - $215,871
-868 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $202,747 - $224,933
868 New
868 $212,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Moneco Advisors, LLC Portfolio

Follow Moneco Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneco Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneco Advisors, LLC with notifications on news.